Skip to main content
Top
Published in: Current Treatment Options in Cardiovascular Medicine 8/2018

01-08-2018 | Vascular Disease (M Weinberg, Section Editor)

Arteriovenous Malformations: Syndrome Identification and Vascular Management

Authors: Allan M. Conway, MD, Robert J. Rosen, MD

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 8/2018

Login to get access

Abstract

Purpose of review

Vascular malformations represent a poorly understood set of conditions that create considerable diagnostic and therapeutic confusion. Historically, extensive surgical resections yielded poor results. More recently, the treatment paradigm has shifted to endovascular therapy such that embolization and sclerotherapy are now considered the first line of treatment. Although there is still a role for traditional surgical techniques, it is now most commonly integrated with endovascular therapies in a hybrid fashion. The goal of this review is to provide a greater understanding of the diagnosis and treatment of vascular malformations.

Recent findings

Vascular malformations can be high-flow (arteriovenous shunting) or low-flow (venous or lymphatic). Clinical presentation and treatment is different for each. Treatment of high-flow lesions must be directed at reducing or eliminating the nidus, usually via super-selective catheterization and embolization. Low-flow lesions are usually treated by direct injection of sclerosing agents under fluoroscopic or ultrasound guidance.

Summary

The cornerstone of managing patients with vascular malformations is making the proper diagnosis, which is often challenging. Even after a diagnosis is made, therapy itself may be challenging and generate frustration among patients and providers. Frequently, the treatment of vascular malformations is characterized by only slow and incremental improvements without complete lesion eradication. By combining a thorough understanding of the vascular malformation disease process with an array of endovascular techniques, vascular interventionalists may contribute greatly to the care of these patients.
Literature
1.
go back to reference Persaud TVN. Problems of birth defects. From Hippocrates to Thalidomide and after. Persaud TVN Part I Belief, mythology, magic and superstition. Commentary. Baltimore: University Park Press Maryland Publishers; 1977. p. 3–4. Persaud TVN. Problems of birth defects. From Hippocrates to Thalidomide and after. Persaud TVN Part I Belief, mythology, magic and superstition. Commentary. Baltimore: University Park Press Maryland Publishers; 1977. p. 3–4.
2.
go back to reference • Belov S. Classification, terminology, and nosology of congenital vascular defects. In: Belov S, Loose DA, Weber J, editors. Vascular malformations. Reinbek: Einhorn-Presse; 1989. p. 25–30.Describing a new classification system for vascular anomalies has emerged that is based on advances in the study of these conditions and is useful in contemporary management • Belov S. Classification, terminology, and nosology of congenital vascular defects. In: Belov S, Loose DA, Weber J, editors. Vascular malformations. Reinbek: Einhorn-Presse; 1989. p. 25–30.Describing a new classification system for vascular anomalies has emerged that is based on advances in the study of these conditions and is useful in contemporary management
4.
go back to reference Paltiel HJ, Burrows PE, Kozakewich HP, Zurakowski D, Mulliken JB. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology. 2000;214(3):747–54.CrossRefPubMed Paltiel HJ, Burrows PE, Kozakewich HP, Zurakowski D, Mulliken JB. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology. 2000;214(3):747–54.CrossRefPubMed
5.
go back to reference Greenspan A, et al. Imaging strategies in the evaluation of soft tissue hemangiomas of the extremities: correlation of the findings of plain radiography, CT, MRI and ultrasonography in 12 histologically proven cases. Skeletal Radiol. 1992;21:8–11.CrossRef Greenspan A, et al. Imaging strategies in the evaluation of soft tissue hemangiomas of the extremities: correlation of the findings of plain radiography, CT, MRI and ultrasonography in 12 histologically proven cases. Skeletal Radiol. 1992;21:8–11.CrossRef
6.
go back to reference Jeon YH, Do YS, Shin SW, et al. Ethanol embolization of arteriovenous malformations: results and complications of 33 cases. J Korean Radiol Soc. 2003;49:263–70.CrossRef Jeon YH, Do YS, Shin SW, et al. Ethanol embolization of arteriovenous malformations: results and complications of 33 cases. J Korean Radiol Soc. 2003;49:263–70.CrossRef
7.
go back to reference Madani H, Farrant J, Chhaya N, Anwar I, Marmery H, Platts A, et al. Peripheral limb vascular malformations: an update of appropriate imaging and treatment options of a challenging condition. Br J Radiol. 2015;88(1047):20140406.CrossRefPubMedPubMedCentral Madani H, Farrant J, Chhaya N, Anwar I, Marmery H, Platts A, et al. Peripheral limb vascular malformations: an update of appropriate imaging and treatment options of a challenging condition. Br J Radiol. 2015;88(1047):20140406.CrossRefPubMedPubMedCentral
8.
go back to reference Blei F, Chianese J. Corticosteroid toxicity in infants treated for endangering hemangiomas: experience and guidelines for monitoring. Intl pediatrics. 1999;14:146–53. Blei F, Chianese J. Corticosteroid toxicity in infants treated for endangering hemangiomas: experience and guidelines for monitoring. Intl pediatrics. 1999;14:146–53.
9.
go back to reference •• Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649–51.Early description of the use of propranolol to inhibit the growth of infantile hemangiomas.CrossRefPubMed •• Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649–51.Early description of the use of propranolol to inhibit the growth of infantile hemangiomas.CrossRefPubMed
10.
go back to reference Natali J, Merland JJ. Superselective arteriography and therapeutic embolization for vascular malformations (angiodysplasias). J Cardiovasc Surg. 1976;17:465. Natali J, Merland JJ. Superselective arteriography and therapeutic embolization for vascular malformations (angiodysplasias). J Cardiovasc Surg. 1976;17:465.
11.
go back to reference Osuga K, Hori S, Kitayoshi H, et al. Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres. J Vasc Interv Radiol. 2002;13(11):1125–33.CrossRefPubMed Osuga K, Hori S, Kitayoshi H, et al. Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres. J Vasc Interv Radiol. 2002;13(11):1125–33.CrossRefPubMed
12.
go back to reference Sasaki GH, Pang CY, Wittliff JL. Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects. Plast Reconstr Surg. 1984;73(3):359–70.CrossRefPubMed Sasaki GH, Pang CY, Wittliff JL. Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects. Plast Reconstr Surg. 1984;73(3):359–70.CrossRefPubMed
13.
go back to reference •• Yakes WF, Haas DK, Parker SH, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology. 1989;170:1059–66.Absolute ethanol was used to perform nine transcatheter embolizations and 21 direct percutaneous puncture embolizations in eight patients with unresectable vascular malformations. The authors showed how ethanol embolotherapy, performed according to strict techniques, can be efficacious in the management of vascular malformations.CrossRefPubMed •• Yakes WF, Haas DK, Parker SH, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology. 1989;170:1059–66.Absolute ethanol was used to perform nine transcatheter embolizations and 21 direct percutaneous puncture embolizations in eight patients with unresectable vascular malformations. The authors showed how ethanol embolotherapy, performed according to strict techniques, can be efficacious in the management of vascular malformations.CrossRefPubMed
14.
go back to reference Kerber C. Intracranial cyoanacrylate: a new catheter therapy for arteriovenous malformation. Invest Radiol. 1975;10:536–8.CrossRefPubMed Kerber C. Intracranial cyoanacrylate: a new catheter therapy for arteriovenous malformation. Invest Radiol. 1975;10:536–8.CrossRefPubMed
15.
go back to reference Vintner V, Galil KA, Lundie MJ, Kaufmann JCE. The histotoxicity of cyanoacrylates. Neuroradiology. 1985;27:279–91.CrossRef Vintner V, Galil KA, Lundie MJ, Kaufmann JCE. The histotoxicity of cyanoacrylates. Neuroradiology. 1985;27:279–91.CrossRef
16.
go back to reference Numan F, Omeroglu A, Kara B, Cantaşdemir M, Adaletli I, Kantarci F. Embolization of peripheral vascular malformations with ethylene vinyl alcohol copolymer (Onyx). J Vasc Interv Radiol. 2004;15(9):939–46.CrossRefPubMed Numan F, Omeroglu A, Kara B, Cantaşdemir M, Adaletli I, Kantarci F. Embolization of peripheral vascular malformations with ethylene vinyl alcohol copolymer (Onyx). J Vasc Interv Radiol. 2004;15(9):939–46.CrossRefPubMed
17.
go back to reference • Conway AM, Qato K, Drury J, Rosen RJ. Embolization techniques for high-flow arteriovenous malformations with a dominant outflow vein. J Vasc Surg Venous Lymphat Disord. 2015;3(2):178–83.The aim of this study was to assess the management and outcomes of arteriovenous malformations (AVMs) with a dominant outflow vein (DOV) treated with retrograde venous embolization. The authors showed how AVMs with a DOV can be successfully treated by a transvenous approach.CrossRefPubMed • Conway AM, Qato K, Drury J, Rosen RJ. Embolization techniques for high-flow arteriovenous malformations with a dominant outflow vein. J Vasc Surg Venous Lymphat Disord. 2015;3(2):178–83.The aim of this study was to assess the management and outcomes of arteriovenous malformations (AVMs) with a dominant outflow vein (DOV) treated with retrograde venous embolization. The authors showed how AVMs with a DOV can be successfully treated by a transvenous approach.CrossRefPubMed
18.
go back to reference Cho SK, Do YS, Kim DI, Kim YW, Shin SW, Park KB, et al. Peripheral arteriovenous malformations with a dominant outflow vein: results of ethanol embolization. Korean J Radiol. 2008;9:258–67.CrossRefPubMedPubMedCentral Cho SK, Do YS, Kim DI, Kim YW, Shin SW, Park KB, et al. Peripheral arteriovenous malformations with a dominant outflow vein: results of ethanol embolization. Korean J Radiol. 2008;9:258–67.CrossRefPubMedPubMedCentral
19.
go back to reference Boxt LM, Levin DC, Fellows KE. Direct puncture angiography in congenital venous malformations. AJR. 1983;140:135.CrossRefPubMed Boxt LM, Levin DC, Fellows KE. Direct puncture angiography in congenital venous malformations. AJR. 1983;140:135.CrossRefPubMed
20.
go back to reference Mitchell S, Shah A, Schwengel D. Pulmonary artery pressure changes during ethanol embolization procedures to treat vascular malformations: can cardiovascular collapse be predicted? JVIR. 2006;17:253–62.CrossRefPubMed Mitchell S, Shah A, Schwengel D. Pulmonary artery pressure changes during ethanol embolization procedures to treat vascular malformations: can cardiovascular collapse be predicted? JVIR. 2006;17:253–62.CrossRefPubMed
22.
go back to reference • Yang Y, Sun M, Ma Q, Cheng X, Ao J, Tian L, et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surgery. 2011;53:150–5.The purpose of this study was to document the results of bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations (LM). These data suggest bleomycin A5 is a safe and effective intralesional agent for the treatment of macrocystic LMs, superficial oral mucosa LM, and localized deep microcystic lesions.CrossRef • Yang Y, Sun M, Ma Q, Cheng X, Ao J, Tian L, et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surgery. 2011;53:150–5.The purpose of this study was to document the results of bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations (LM). These data suggest bleomycin A5 is a safe and effective intralesional agent for the treatment of macrocystic LMs, superficial oral mucosa LM, and localized deep microcystic lesions.CrossRef
23.
go back to reference Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int. 2004;19:766–73.CrossRefPubMed Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int. 2004;19:766–73.CrossRefPubMed
24.
go back to reference Khmamouche MR, Debbagh A, Mahfoud T, Aassab R, Lkhoyaali S, Ichou M, et al. Flagellate erythema secondary to bleomycin: a new case report and review of the literature. J Drugs Dermatol. 2014;13(8):983–4.PubMed Khmamouche MR, Debbagh A, Mahfoud T, Aassab R, Lkhoyaali S, Ichou M, et al. Flagellate erythema secondary to bleomycin: a new case report and review of the literature. J Drugs Dermatol. 2014;13(8):983–4.PubMed
25.
go back to reference Klippel M, Trenaunay P. Du naevus variqueux osterhypertrophique. Arch Gen Med (Paris). 1900;3:611. Klippel M, Trenaunay P. Du naevus variqueux osterhypertrophique. Arch Gen Med (Paris). 1900;3:611.
26.
go back to reference Parkes Weber F. Haemangiectatic hypertrophy of the limbs: congenital phlebarterietasis and so-called congenital varicose veins. Br J Child Dis. 1918;15:13. Parkes Weber F. Haemangiectatic hypertrophy of the limbs: congenital phlebarterietasis and so-called congenital varicose veins. Br J Child Dis. 1918;15:13.
27.
go back to reference Huang Y, Jiang M, Li W. Endovenous laser treatment combined with a surgical strategy for treatment of venous insufficiency in lower extremity: report of 208 cases. J Vasc Surg. 2005;42(3):494–501.CrossRefPubMed Huang Y, Jiang M, Li W. Endovenous laser treatment combined with a surgical strategy for treatment of venous insufficiency in lower extremity: report of 208 cases. J Vasc Surg. 2005;42(3):494–501.CrossRefPubMed
28.
go back to reference • Howlett DC, Roebuck DJ, Frazer CK, Ayers B. The use of ultrasound in the venous assessment of lower limb Klippel-Trenaunay syndrome. Eur J Radiol. 1994;18:224–6.Colour Doppler ultrasound was used to study the affected lower limbs of a group of patients with the Klippel-Trenaunay syndrome. From this study, the deep venous aplasia said to occur in the condition would appear to be less common than previously thought.CrossRefPubMed • Howlett DC, Roebuck DJ, Frazer CK, Ayers B. The use of ultrasound in the venous assessment of lower limb Klippel-Trenaunay syndrome. Eur J Radiol. 1994;18:224–6.Colour Doppler ultrasound was used to study the affected lower limbs of a group of patients with the Klippel-Trenaunay syndrome. From this study, the deep venous aplasia said to occur in the condition would appear to be less common than previously thought.CrossRefPubMed
29.
go back to reference Greinwald JH Jr, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM, et al. Treatment of lymphangiomas in children: an update of picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg. 1999;121(4):381–7.CrossRefPubMed Greinwald JH Jr, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM, et al. Treatment of lymphangiomas in children: an update of picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg. 1999;121(4):381–7.CrossRefPubMed
30.
go back to reference Kinmonth JB, Young AE, Edwards JM, O'Donnell TF, Thomas ML. Mixed vascular deformities of the lower limbs, with particular reference to lymphography and surgical treatment. Br J Surg. 1976;63(12):899–906.CrossRefPubMed Kinmonth JB, Young AE, Edwards JM, O'Donnell TF, Thomas ML. Mixed vascular deformities of the lower limbs, with particular reference to lymphography and surgical treatment. Br J Surg. 1976;63(12):899–906.CrossRefPubMed
31.
go back to reference Mendel T, Louis DS. Major vascular malformations of the upper extremity: long-term observation. J Hand Surg. 1997;22A:302.CrossRef Mendel T, Louis DS. Major vascular malformations of the upper extremity: long-term observation. J Hand Surg. 1997;22A:302.CrossRef
32.
go back to reference Cronenwett JL, Johnston KW. Rutherford’s vascular surgery. 7th ed. Philadelphia: Saunders Elsevier; 2010. p. 1072–5. Cronenwett JL, Johnston KW. Rutherford’s vascular surgery. 7th ed. Philadelphia: Saunders Elsevier; 2010. p. 1072–5.
33.
go back to reference Pireau N, Boon LM, Poilvache P, Docquier PL. Surgical treatment of intra-articular knee venous malformations: when and how? J Pediatr Orthop. 2016;36(3):316–22.CrossRefPubMed Pireau N, Boon LM, Poilvache P, Docquier PL. Surgical treatment of intra-articular knee venous malformations: when and how? J Pediatr Orthop. 2016;36(3):316–22.CrossRefPubMed
34.
go back to reference Johnson JN, Shaughnessy WJ, Stans AA. Management of knee arthropathy in patients with vascular malformations. J Pediatr Orthop. 2009;29(4):380–4.CrossRefPubMed Johnson JN, Shaughnessy WJ, Stans AA. Management of knee arthropathy in patients with vascular malformations. J Pediatr Orthop. 2009;29(4):380–4.CrossRefPubMed
35.
go back to reference Cil BE, Vargel I, Geyik S, Peynircioglu B, Cavusoglu T. Venous vascular malformations of the craniofacial region: pre-operative embolisation with direct percutaneous puncture and N-butyl cyanoacrylate. Br J Radiol. 2008;81(972):935–9.CrossRefPubMed Cil BE, Vargel I, Geyik S, Peynircioglu B, Cavusoglu T. Venous vascular malformations of the craniofacial region: pre-operative embolisation with direct percutaneous puncture and N-butyl cyanoacrylate. Br J Radiol. 2008;81(972):935–9.CrossRefPubMed
36.
go back to reference James CA, Braswell LE, Wright LB. Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up. J Vasc Intervent Radiol. 2011;22(7):953–60.CrossRef James CA, Braswell LE, Wright LB. Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up. J Vasc Intervent Radiol. 2011;22(7):953–60.CrossRef
38.
Metadata
Title
Arteriovenous Malformations: Syndrome Identification and Vascular Management
Authors
Allan M. Conway, MD
Robert J. Rosen, MD
Publication date
01-08-2018
Publisher
Springer US
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 8/2018
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-018-0662-7

Other articles of this Issue 8/2018

Current Treatment Options in Cardiovascular Medicine 8/2018 Go to the issue

Women’s Health (M Wood, Section Editor)

Cardiac Adaption to Exercise Training: the Female Athlete

Pregnancy and Cardiovascular Disease (N Scott, Section Editor)

Cardiac Arrhythmias and Pregnancy

Pregnancy and Cardiovascular Disease (N Scott, Section Editor)

Anesthetic Treatment of Cardiac Disease During Pregnancy

Vascular Disease (M Weinberg, Section Editor)

Venous Obstruction in Cardiac Rhythm Device Therapy

Pregnancy and Cardiovascular Disease (N Scott, Section Editor)

Management of Venous Thromboembolism in Pregnancy